Phase II trial of GM-CSF as maintenance therapy post-autologous peripheral blood stem cell transplantation in multiple myeloma

被引：0
|
作者：
Mandanas, RA [1 ]
Beveridge, R [1 ]
Rifkin, RM [1 ]
Greenspan, AR [1 ]
Orloff, GJ [1 ]
Klein, LM [1 ]
Rauch, MA [1 ]
Boehm, KA [1 ]
Zhan, F [1 ]
Asmar, L [1 ]
机构：
[1] US Oncol Res Inc, Houston, TX USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.221
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
221
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [31] Autologous bone marrow and peripheral blood stem cell transplantation in multiple myeloma
    Vesole, DH
    Jagannath, S
    Tricot, G
    Desikan, KR
    Siegel, D
    Barlogie, B
    CANCER INVESTIGATION, 1996, 14 (04) : 378 - 391
  • [32] Cost analysis of autologous peripheral blood stem cell transplantation for multiple myeloma
    Mishra, V
    Vaaler, S
    Brinch, L
    CLINICAL AND LABORATORY HAEMATOLOGY, 2003, 25 (03): : 179 - 184
  • [33] Plasmablastic transformation of multiple myeloma post-autologous hematopoietic stem cell transplant
    Akbar, Nurul Asyikin Nizam
    Hassan, Mohd Nazri
    Iberahim, Salfarina
    Saidin, Nur Ilyia Syazwani
    Roslan, Wardah
    Halim, Nur Ain Izzati Abd
    Abdullah, Abu Dzarr
    Hanafi, Hany Hakimi Wan
    Shukri, Nur Diyana Mohd
    Adzahar, Sumaiyah
    BIOMEDICAL RESEARCH AND THERAPY, 2023, 10 (08): : 5796 - 5800
  • [34] Lenalidomide vs. bortezomib maintenance choice post-autologous haematopoietic cell transplantation (AHCT) for multiple myeloma
    Huang, J.
    Phillips, S.
    Rawling, K.
    Cornell, R. F.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S465 - S465
  • [35] RANDOMIZED STUDY OF GM-CSF POST PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANT WITH PBSC COLLECTED WITH GM-CSF IN LYMPHOMAS
    COLOMBAT, P
    GARDEMBAS, M
    DELWAIL, V
    MILPIED, N
    ABGRALL, JF
    CHASSAGNE, I
    TABAH, E
    DELAIN, M
    BLOOD, 1994, 84 (10) : A705 - A705
  • [36] Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT)
    Arpaci, F
    Dogru, T
    Ozturk, B
    Komurcu, S
    Ozet, A
    Yilmaz, MI
    Beyzadeoglu, M
    Turan, A
    Sengul, A
    Yalcin, A
    HAEMATOLOGIA, 2002, 32 (03) : 253 - 264
  • [37] Phase 1 Study of Elotuzumab and Peripheral Blood Mononuclear Cell Reconstitution in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma
    Osman, Keren
    Chari, Ajai
    Parekh, Samir
    Aleman, Adolfo
    Caro, Jessica
    Morgan, Gillian
    Florendo, Erika
    Chan, Elaine
    Strumolo, Gina
    Zarychta, Katarzyna
    La, Lisa
    Mandeli, John
    Kim-Schultze, Seunghee
    Gnjatic, Sacha
    Jagannath, Sundar
    Cho, Hearn Jay
    BLOOD, 2017, 130
  • [38] GM-CSF mobilised peripheral blood progenitor cell transplantation (PBPCT) vs autologous bone marrow transplantation (ABMT).
    Kumar, L
    Kochupillai, V
    Raju, GMK
    Sharma, A
    Chandy, L
    BLOOD, 1996, 88 (10) : 3674 - 3674
  • [39] Use of Maintenance Therapy Post Autologous Stem Cell Transplantation Outside of Clinical Trial Setting for Multiple Myeloma: Single Institution Experience
    Karam, Dhauna
    Gertz, Morie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Dingli, David
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Warsame, Rahma M.
    Hogan, William J.
    Kumar, Shaji K.
    BLOOD, 2019, 134
  • [40] REVISITING THE UTILITY OF G-CSF POST-AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Portuguese, Andrew
    Hill, Geoffrey
    Holmberg, Leona
    Lee, Stephanie
    Green, Damian
    Mielcarek, Marco
    Yeh, Albert
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 482 - 483
12345